Skip to main content
AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
18.95
+0.30 (1.61%)
At close: Mar 28, 2025, 4:00 PM
19.04
+0.09 (0.48%)
After-hours: Mar 28, 2025, 7:55 PM EDT

AnaptysBio Revenue

In the year 2024, AnaptysBio had annual revenue of $91.28M with 432.03% growth. AnaptysBio had revenue of $43.11M in the quarter ending December 31, 2024, with 378.77% growth.

Revenue (ttm)
$91.28M
Revenue Growth
+432.03%
P/S Ratio
5.89
Revenue / Employee
$671,176
Employees
136
Market Cap
581.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202491.28M74.12M432.03%
Dec 31, 202317.16M6.87M66.78%
Dec 31, 202210.29M-52.89M-83.72%
Dec 31, 202163.18M-11.83M-15.77%
Dec 31, 202075.00M67.00M837.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ANAB News

More News